Experience

• 

  Arthur andersen & co.

  Sept 1999 - Aug 2001

  Staff accountant
• 

  Merck

  Aug 2001 - Jun 2021

  Organon & Co., Inc. is a wholly owned subsidiary of Merck & Co., Inc., scheduled to spin off as a separate company in 2021 Actuals Reporting Benefits Finance - Pensions Diversified Brands Customer Business Line(formerly supporting Cardiovascular, Osteoporosis and Pain franchises) Audit Project Manager (2/2005 – 12/2005); Audit Supervisor (1/2004 – 1/2005); Supervising Senior Auditor (2/2003 – 12/2003); Senior Auditor (4/2002 – 1/2003); Audit Specialist (8/2001 – 4/2002)

  • Director, Corporate Audit & Assurance Services, appointed for Organon

    Feb 2021 - Jun 2021

  • Associate Director, Merck Corporate Audit & Assurance Services

    Feb 2019 - Jan 2021

  • Associate Director, Finance Planning & Analysis - Corporate Financial Services

    Jan 2018 - Feb 2019

  • Associate Director, Treasury Central Services

    Feb 2014 - Dec 2017

  • Associate Director, Financial Planning & Analysis - Global Human Health Finance

    Apr 2010 - Feb 2014

  • Finance Manager - Global Medical Affairs (Schering-Plough)

    Dec 2005 - Mar 2010

  • Audit Manager (Schering-Plough)

    Aug 2001 - Dec 2005
• 

  Organon

  Jun 2021 - now

  Director, corporate audit & assurance services